During further screening of crucial targets by using molecular docking analysis, the Pachyman-activated anti-HCC core targets, including ALB and VEGFA, were identified accordingly, characterized with potent binding activities of Pachyman with 6QIO and 5T89 proteins in HCC. Here, VEGFA is linked to hepatocellular carcinoma.